PGR and breast cancer: BC can be subdivided into four main molecular subtypes (luminal B, luminal A, triple-negative (TN), and Her2-enriched) on the basis of the expression of the progesterone receptor (PR), epidermal growth factor receptor 2 (ERBB2, also called HER2), and estrogen receptor (ER) [10].